Andesa Financial Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,254
Closed -$295K 143
2022
Q4
$295K Sell
3,254
-999
-23% -$84.1K 0.16% 118
2022
Q3
$324K Buy
4,253
+1,364
+47% +$113K 0.11% 118
2022
Q2
$244K Buy
2,889
+41
+1% +$3.6K 0.15% 120
2022
Q1
$249K Sell
2,848
-438
-13% -$37.9K 0.13% 132
2021
Q4
$287K Sell
3,286
-177
-5% -$14.7K 0.14% 127
2021
Q3
$283K Sell
3,463
-1,312
-27% -$118K 0.15% 112
2021
Q2
$435K Sell
4,775
-809
-14% -$72K 0.13% 107
2021
Q1
$477K Buy
5,584
+78
+1% +$7K 0.16% 93
2020
Q4
$519K Sell
5,506
-1,627
-23% -$142K 0.34% 69
2020
Q3
$620K Buy
7,133
+1,805
+34% +$156K 0.26% 71
2020
Q2
$468K Sell
5,328
-676
-11% -$58.4K 0.42% 63
2020
Q1
$494K Buy
6,004
+164
+3% +$14.6K 0.55% 49
2019
Q4
$554K Buy
5,840
+152
+3% +$13.6K 0.48% 51
2019
Q3
$494K Sell
5,688
-3,202
-36% -$288K 0.48% 48
2019
Q2
$812K Sell
8,890
-11,298
-56% -$956K 0.77% 34
2019
Q1
$1.74M Buy
20,188
+10,378
+106% +$833K 0.86% 32
2018
Q4
$752K Buy
+9,810
New +$764K 0.9% 34

Other funds holding NVS

Andesa Financial Management's NVS Position: Q1 2023 in Review

Andesa Financial Management sold out of Novartis (NVS) in Q1 2023, closing a stake of 3,254 shares — an estimated $295K sold.

Andesa Financial Management first reported a position in NVS in Q4 2018 and held it in 17 quarters. The position peaked at $1.74M in Q1 2019. 1,181 funds tracked by Wall St. Rank hold NVS as of Q1 2023.

  • Andesa Financial Management reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
  • Andesa Financial Management sold 3,254 Novartis shares in Q1 2023, an estimated $295K.
  • Andesa Financial Management first reported a position in Novartis in Q4 2018 and held it in 17 quarters.
  • Andesa Financial Management's Novartis position peaked at $1.74M in Q1 2019.
  • 1,181 funds tracked by Wall St. Rank held Novartis as of Q1 2023.

Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.